US Retina Health Market Insights for Modern Ophthalmology
The US Retina Health Market outlook remains exceptionally positive as gene therapy pipelines mature and reach pivotal clinical milestones. With RGX-314 from Regenxbio/AbbVie and Ixo-vec from Adverum Biotechnologies advancing through Phase III trials, the prospect of one-time treatments for wet AMD and diabetic retinopathy is drawing closer to reality. The market benefits from FDA incentives...
0 التعليقات 0 المشاركات 121 مشاهدة 0 معاينة